Research & Development Aim to provide solutions to unmet medical needs
in the field of gastrointestinal disease
EA Pharma Co., Ltd. promotes drug discovery and clinical development targeting IBD (Inflammatory Bowel Disease) and a wide range of other gastrointestinal diseases to launch new drugs and treatment methods that can provide solutions to unmet medical needs.
Emphasizing the deep understanding about pathology and actual healthcare situations as well as the ideas inspired by them, EA Pharma Co., Ltd. also introduces external ideas and innovative technologies through public offering of research seeds by academia and research institutes and joint research projects with other companies to create unique value as a Japanese specialty pharma.
Technology to manufacture pharmaceuticals Stable supply of high-quality products
Manufacturing safe and secure pharmaceuticals
The missions of production department are to manufacture pharmaceuticals with efficacy and safety that meet the associated expectations of patients and to assure the quality of all products. Our production plants are equipped with high-performance production equipment as well as the most advanced production and quality control systems. Under a comprehensive quality assurance system where the processes from raw materials receiving through shipping of products conform to GMP*, we execute the “production of safe and secure pharmaceuticals” with sophisticated technologies.
We continue to strengthen the production system for more stable supply and cost competitiveness, and also offer contract manufacturing services with full support systems that cover a wide range from manufacture through to packaging of solid products, ointments and suppositories.
- *GMP Good Manufacturing Practice
Reliability assurance of pharmaceuticals Stable provision of reliable pharmaceuticals
Strive to improve our products with further increases in quality, efficacy and safety
Reliability assurance is indispensable for safe and effective use of pharmaceuticals by patients and medical professionals. Throughout the entire product life cycle from research & development, to filing an application for marketing authorization and approval through to post marketing, we promote reliability assurance of the data relating to product quality, safety including side effect information and other product data. For pharmaceuticals, there are regulatory standards* in various aspects to ensure the reliability of products and data. Not only do we conform to the standards, we are consciously aware of the gravity of the fact that our products directly relate to the life of users. Our basic stance is placing ourselves in patient’s position. We actively respond to regulatory requirements, communicate with regulatory administrative, and promote improvement of product quality, collection and provision of safety and efficacy data to increase reliability of our products.
- *GLP Good Laboratory Practice
- GCP Good Clinical Practice
- GMP Good Manufacturing Practice
- GQP Good Quality Practice
- GVP Good Vigilance Practice
- GPSP Good Post-Marketing Study Practice
Dissemination of medical information For better health and quality of life for individual patients
A bridge between healthcare provider and pharmaceutical manufacturer
Pharmaceuticals exert their expected efficacy when used appropriately. For this purpose, pharmaceutical manufacturers are required to provide physicians, pharmacists and other medical practitioners with appropriate information.
Our medical representatives (MRs) continuously receive training daily in oder to be fully equipped with broader knowledge not only of our own products but also of diseases and treatments as well to be able to provide high quality information that will be useful in the clinical setting. MRs communicate with medical practitioners in accordance with applicable laws and regulations ,and also collect information in the field. MRs deliver the information they collect from medical practitioners to the research and development departments, and the information is utilized in development of new products.
Through these information-providing activities, MRs work to be reliable and trusted partners for patients and healthcare professionals.
